BNO 5.26% 20.0¢ bionomics limited

H.C Wainwright report Val 75c, page-6

  1. 44 Posts.
    Most shareholders appear to have accepted the companies comments that the trial was a "failure" and that the boards job is to resurrect everything.
    If I was the BNO board I would certainly be saying that as how else can you justify the share price decline unless it was a failure.
    Possibly Wainwright are better at actually understanding the data for BNC210 rather than the interpretation of others.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.